Cumberland Pharmaceuticals (CPIX) Change in Accured Expenses (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Change in Accured Expenses data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 124.34% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (up 730.44% YoY), and the FY2025 full-year result was $6.7 million, up 776.77% from the prior year.
• Change in Accured Expenses retreated to -$1.3 million in Q1 2026, from $8.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $8.0 million in Q4 2025 to a low of -$3.3 million in Q4 2023.
• A 5-year average of $1.0 million and a median of $197393.0 in 2022 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses soared 2957.92% in 2022 and slumped 185.82% in 2024, its largest moves.
• Tracing CPIX's Change in Accured Expenses over 5 years: stood at $5.8 million in 2022, then tumbled by 157.46% to -$3.3 million in 2023, then jumped by 90.2% to -$324294.0 in 2024, then soared by 2580.43% to $8.0 million in 2025, then tumbled by 116.73% to -$1.3 million in 2026.
• Business Quant data shows CPIX's Change in Accured Expenses at -$1.3 million in Q1 2026, $8.0 million in Q4 2025, and $684224.0 in Q3 2025.